BBVA USA Bancshares’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $3.15M | Sell |
42,858
-9,801
| -19% | -$723K | 0.15% | 149 |
|
|
2020
Q4 | $4.11M | Sell |
52,659
-1,250
| -2% | -$95.6K | 0.21% | 114 |
|
|
2020
Q3 | $4.21M | Sell |
53,909
-10,041
| -16% | -$786K | 0.24% | 101 |
|
|
2020
Q2 | $4.72M | Sell |
63,950
-11,456
| -15% | -$862K | 0.28% | 92 |
|
|
2020
Q1 | $5.54M | Buy |
75,406
+730
| +1% | +$57.4K | 0.4% | 64 |
|
|
2019
Q4 | $6.48M | Sell |
74,676
-495
| -0.7% | -$40.7K | 0.37% | 65 |
|
|
2019
Q3 | $6.04M | Sell |
75,171
-77
| -0.1% | -$6.17K | 0.39% | 66 |
|
|
2019
Q2 | $6.02M | Sell |
75,248
-522
| -0.7% | -$40K | 0.36% | 66 |
|
|
2019
Q1 | $6.01M | Sell |
75,770
-3,288
| -4% | -$246K | 0.38% | 66 |
|
|
2018
Q4 | $5.76M | Buy |
79,058
+4,671
| +6% | +$330K | 0.41% | 63 |
|
|
2018
Q3 | $5.04M | Buy |
74,387
+5,750
| +8% | +$366K | 0.3% | 82 |
|
|
2018
Q2 | $3.98M | Sell |
68,637
-2,735
| -4% | -$154K | 0.25% | 95 |
|
|
2018
Q1 | $3.71M | Sell |
71,372
-12,378
| -15% | -$669K | 0.24% | 99 |
|
|
2017
Q4 | $4.5M | Sell |
83,750
-20,838
| -20% | -$1.16M | 0.29% | 86 |
|
|
2017
Q3 | $6.39M | Sell |
104,588
-14,880
| -12% | -$902K | 0.42% | 59 |
|
|
2017
Q2 | $7.31M | Sell |
119,468
-2,724
| -2% | -$166K | 0.48% | 54 |
|
|
2017
Q1 | $7.41M | Sell |
122,192
-7,421
| -6% | -$450K | 0.5% | 49 |
|
|
2016
Q4 | $7.28M | Sell |
129,613
-6,068
| -4% | -$355K | 0.51% | 48 |
|
|
2016
Q3 | $8.08M | Buy |
135,681
+966
| +0.7% | +$56.5K | 0.58% | 42 |
|
|
2016
Q2 | $7.41M | Sell |
134,715
-3,303
| -2% | -$176K | 0.56% | 43 |
|
|
2016
Q1 | $6.97M | Sell |
138,018
-2,214
| -2% | -$108K | 0.53% | 46 |
|
|
2015
Q4 | $7.07M | Sell |
140,232
-19,471
| -12% | -$982K | 0.53% | 47 |
|
|
2015
Q3 | $7.53M | Sell |
159,703
-207,429
| -56% | -$11M | 0.59% | 38 |
|
|
2015
Q2 | $19.9M | Sell |
367,132
-2,830
| -0.8% | -$159K | 1.11% | 18 |
|
|
2015
Q1 | $20.3M | Sell |
369,962
-9,346
| -2% | -$529K | 0.91% | 23 |
|
|
2014
Q4 | $20.6M | Sell |
379,308
-26,259
| -6% | -$1.46M | 0.93% | 19 |
|
|
2014
Q3 | $22.9M | Buy |
405,567
+19,987
| +5% | +$1.12M | 1.02% | 18 |
|
|
2014
Q2 | $21.3M | Buy |
385,580
+8,934
| +2% | +$487K | 0.93% | 20 |
|
|
2014
Q1 | $20.4M | Sell |
376,646
-19,658
| -5% | -$1.02M | 0.93% | 22 |
|
|
2013
Q4 | $18.9M | Buy |
396,304
+19,640
| +5% | +$898K | 0.83% | 28 |
|
|
2013
Q3 | $17.1M | Buy |
376,664
+17,415
| +5% | +$795K | 0.82% | 28 |
|
|
2013
Q2 | $15.9M | Buy |
+359,249
| New | +$16M | 0.81% | 30 |
|
Other funds holding MRK
BBVA USA Bancshares's MRK Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Merck (MRK) stake by 19% in Q1 2021, selling an estimated $723K and leaving 42,858 shares worth $3.15M. The position accounts for 0.15% of the portfolio, ranked #149.
BBVA USA Bancshares first reported a position in MRK in Q2 2013 and has held it in 32 quarters since. The position peaked at $22.9M in Q3 2014. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.
- BBVA USA Bancshares held 42,858 shares of Merck worth $3.15M as of Q1 2021.
- BBVA USA Bancshares sold 9,801 Merck shares in Q1 2021, an estimated $723K.
- Merck made up 0.15% of BBVA USA Bancshares's portfolio in Q1 2021, its #149 holding.
- BBVA USA Bancshares first reported a position in Merck in Q2 2013 and has held it in 32 quarters since.
- BBVA USA Bancshares's Merck position peaked at $22.9M in Q3 2014.
- 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.